Thomas P Kunkle, PHD. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 335 Buckeye Blvd, Port Clinton, OH 43452 Phone: 419-734-2942 |
Ashley Knight, M.ED., ED.S., NCSP Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 821 Jefferson St, Port Clinton, OH 43452 Phone: 419-734-2147 |
Peter B Casgrain, PHD Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 3872 E Harbor Light Landing Dr, Port Clinton, OH 43452 Phone: 419-734-3333 Fax: 419-734-3335 |
Dr. Alice H Randolph, EDD MSCP Psychologist - Clinical Medicare: Accepting Medicare Assignments Practice Location: 3872 E Harbor Light Landing Dr, Port Clinton, OH 43452 Phone: 216-215-8000 Fax: 877-734-2032 |
Debra L Derbyshire, PHD Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 205 Se Catawba Rd, Suite A, Port Clinton, OH 43452 Phone: 419-734-3333 Fax: 419-734-3335 |
Mrs. Lisa Maletich Psychologist - School Medicare: Not Enrolled in Medicare Practice Location: 821 Jefferson St, Port Clinton, OH 43452 Phone: 419-734-2147 Fax: 419-732-0892 |
News Archive
The government alleged that the drug company and its subsidiaries promoted psychiatric medications for uses that had not been approved by the Food and Drug Administration.
Two types of human antibodies that target different parts of the Ebola virus synergize their antiviral effects by inhibiting different steps of infection, according to a study published August 23 in the open-access journal PLOS Pathogens by Philipp Ilinykh and colleagues from the University of Texas Medical Branch, Vanderbilt University, and Ragon Institute.
Eighty-three percent of the owners of small businesses surveyed across Michigan do not support a government-operated health care plan as a public option for insurance, according to a new survey of the members of the Michigan Business and Professional Association (MBPA) and the Michigan Food and Beverage Association (MFBA) headquartered in Warren. This is intriguing data as Michigan's economy has been under national scrutiny and the bills were designed to help small business.
ReVision Optics, a leading company in the research, development and manufacture of implantable medical devices designed to assist patients that need reading glasses, announced today that it has completed enrollment and initial follow up in Phase I of its US clinical trial and has filed for expansion. The clinical trial is for the study of the PresbyLens, recently renamed Vue+, for the improvement of near vision in patients with presbyopia, the age-related loss of near vision.
› Verified 4 days ago